Egypt, China sign deal to build level-3 biosafety lab    Foreign, housing ministers discuss Egypt's role in African development push    Egypt backs Palestinian unity, calls for ceasefire, aid access    EGX ends week in green on July 10    Egyptian pound strengthens against US dollar on July 10    Egypt, China central banks sign pacts to boost yuan use, payment systems    Egypt's EDA, Haleon discuss local market support    Environment ministry signs agreement to strengthen marine protection, promote ecotourism    Egypt, WHO discuss expanding health cooperation, development initiatives    Service restoration underway after Cairo telecom fire, minister tells PM    Chinese Premier Li Qiang arrives in Egypt for high-level talks    Gaza under siege, fire: Resistance intensifies amid deepening humanitarian collapse    Korea Culture Week in Egypt to blend K-Pop with traditional arts    Egypt, Pakistan boost healthcare ties – Cabinet    UK, Egypt strengthen cooperation on green transition, eco-tourism, and environmental investments    Escalation in Gaza as ceasefire talks remain fragile amid mounting humanitarian crisis    CIB finances Giza Pyramids Sound and Light Show redevelopment with EGP 963m loan    Egypt's PM, Uruguay's president discuss Gaza, trade at BRICS summit    Greco-Roman tombs with hieroglyphic inscriptions discovered in Aswan    Egypt reveals heritage e-training portal    Three ancient rock-cut tombs discovered in Aswan    Egypt condemns deadly terrorist attack in Niger        Sisi launches new support initiative for families of war, terrorism victims    Egypt's GAH, Spain's Konecta discuss digital health partnership    Egypt expands e-ticketing to 110 heritage sites, adds self-service kiosks at Saqqara    Egypt's Irrigation Minister urges scientific cooperation to tackle water scarcity    Palm Hills Squash Open debuts with 48 international stars, $250,000 prize pool    Egypt's Democratic Generation Party Evaluates 84 Candidates Ahead of Parliamentary Vote    On Sport to broadcast Pan Arab Golf Championship for Juniors and Ladies in Egypt    Golf Festival in Cairo to mark Arab Golf Federation's 50th anniversary    Germany among EU's priciest labour markets – official data    Cabinet approves establishment of national medical tourism council to boost healthcare sector    Egypt's PM follows up on Julius Nyerere dam project in Tanzania    Paris Olympic gold '24 medals hit record value    A minute of silence for Egyptian sports    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Major European nations suspend use of AstraZeneca vaccine
Published in Ahram Online on 16 - 03 - 2021

A cascading number of European countries _ including Germany, France, Italy and Spain _ suspended use of AstraZeneca's COVID-19 vaccine Monday over reports of dangerous blood clots in some recipients, though the company and international regulators say there is no evidence the shot is to blame.
AstraZeneca's formula is one of three vaccines in use on the continent. But the escalating concern is another setback for the European Union's vaccination drive, which has been plagued by shortages and other hurdles and is lagging well behind the campaigns in Britain and the U.S.
The EU's drug regulatory agency called a meeting for Thursday to review experts' findings on the AstraZeneca shot and decide whether action needs to be taken.
The furor comes as much of Europe is tightening restrictions on schools and businesses amid surging cases of COVID-19.
Germany's health minister said the decision to suspend AstraZeneca shots was taken on the advice of the country's vaccine regulator, the Paul Ehrlich Institute, which called for further investigation into seven cases of clots in the brains of people who had been vaccinated.
``Today's decision is a purely precautionary measure,'' Jens Spahn said.
French President Emmanuel Macron said his country will likewise stop dispensing the vaccine until at least Tuesday afternoon. Italy also announced a temporary ban, as did Spain, Portugal and Slovenia.
Other countries that have done so over the past few days include Denmark, which was the first, as well as Ireland, Thailand, the Netherlands, Norway, Iceland, Congo and Bulgaria. Canada and Britain are standing by the vaccine for now.
In the coming weeks, AstraZeneca is expected to apply for U.S. authorization of its vaccine. The U.S. now relies on Pfizer's, Moderna's and Johnson & Johnson's shots.
AstraZeneca said there have been 37 reports of blood clots out of more than 17 million people vaccinated in the 27-country EU and Britain. The drugmaker said there is no evidence the vaccine carries an increased risk of clots.
In fact, it said the incidence of clots is much lower than would be expected to occur naturally in a general population of this size and is similar to that of other licensed COVID-19 vaccines.
The World Health Organization and the EU's European Medicines Agency have also said that the data does not suggest the vaccine caused the clots and that people should continue to be immunized.
``Many thousands of people develop blood clots annually in the EU for different reasons,'' the European Medicines Agency said. The incidence in vaccinated people ``seems not to be higher than that seen in the general population.''
The agency said that while the investigation is going on, ``the benefits of the AstraZeneca vaccine in preventing COVID-19, with its associated risk of hospitalization and death, outweigh the risks of side effects.''
Blood clots can travel through the body and cause heart attacks, strokes and deadly blockages in the lungs. AstraZeneca reported 15 cases of deep vein thrombosis, or a type of clot that often develops in the legs, and 22 instances of pulmonary embolisms, or clots in the lungs.
The AstraZeneca shot has become a key tool in European countries' efforts to boost their sluggish vaccine rollouts. It is also pillar of a U.N.-backed project known as COVAX that aims to supply COVID-19 vaccines to poorer countries. That program continues unaffected by the European suspension.
Pfizer's and Moderna's vaccines are also used on the European continent, and J&J's one-shot vaccine has been authorized but not yet delivered.
Dr. Michael Head, a senior research fellow in global health at the University of Southampton in England, said there is no data yet to justify suspending the AstraZeneca vaccine and called the decision ``baffling.``
``Halting a vaccine rollout during a pandemic has consequences,'' Head said. ``This results in delays in protecting people, and the potential for increased vaccine hesitancy, as a result of people who have seen the headlines and understandably become concerned.``
Spahn, the German health minister, defended the country's decision, saying, ``The most important thing for confidence is transparency.'' He said both first and second doses would be suspended.
Germany has received slightly over 3 million doses of the AstraZeneca vaccine, and about half of those have so far been administered, compared with almost 7 million of the Pfizer shot and about 285,000 from Moderna.
German authorities have encouraged anyone who feels increasingly ill more than four days after receiving the shot _ for example, with persistent headaches or dot-shaped bruises _ to seek medical attention.
The head of the Spanish Medicines Agency, Maria Jesus Lamas, said Spain detected its first case of clots on Saturday. She said the ban was ``not an easy decision'' because it further slows the nation's vaccination campaign, but it was the ``most prudent'' approach.
Almost 940,000 people in Spain have received the AstraZeneca shot.
Some European countries, meanwhile, have begun reimposing restrictions in a bid to beat back a resurgence in infections, many of them from variants of the original virus.
In Italy, 80% of children nationwide couldn't attend classes after stricter rules in more regions took effect on Monday. In Poland, bolstered restrictions were applied to two more regions, including Warsaw. Paris could go into lockdown in a matter of days because intensive care units are getting swamped with COVID-19 patients.
And calls are growing in Germany to `` pull the emergency brake'' in regions where cases are rising.


Clic here to read the story from its source.